All Enquiries articles
-
OpinionDeadly fentanyl contamination exposes drug safety challenges
Bacterial contamination in medical fentanyl has killed at least 51 people in Argentina, highlighting pressures on generic drugmakers
-
NewsForty years on from the Bhopal disaster what lessons have been learnt?
India looks to the future as survivors fight on to receive adequate compensation and medical care
-
BusinessFormer Ranbaxy owners arrested for fraud
Singh brothers accused of misappropriation, as well as not paying previous fines relating to Ranbaxy’s takeover by Daiichi Sankyo
-
NewsResearch would be a ‘casualty’ if English higher education review acted on, Lords warn
Many other areas could suffer too including student lab practicals and infrastructure maintenance
-
NewsJust six sexual harassment complaints were received by four of the US’s top funding bodies – over four years
Nasa, energy and agriculture departments and National Institutes of Health all received fewer than three complaints
-
NewsForensic science failures putting justice at risk in England and Wales
Damning House of Lords report says cuts and bureaucracy may result in the market for forensics becoming dysfunctional
-
NewsRogue Chinese scientist to be punished for creation of first gene-edited humans
Investigation uncovers forged ethical approval documents
-
BusinessVaccine scandal and heart drug recall show China’s pharma struggles
Fifteen arrests amid evidence of bribery related to vaccines, despite new standards and penalties for fraud
-
NewsOPCW to identify perpetrators of chemical attacks
The international watchdog wants to ensure those responsible for the use of chemical weapons are ‘held accountable’
-
BusinessUS chemical safety agency wants Arkema disaster to spark real change
Industry guidance is needed to help hazardous chemical facilities better prepare for extreme weather events like flooding, the CSB warns
-
BusinessUS senators launch probe of Novartis’ payments to Trump lawyer
Congress demands info from Novartis about its $1.2m in outflows to Michael Cohen, just as it was negotiating payments for its cancer drug
-
BusinessUS probes opioid manufacturers
Attorneys general from 41 states will investigate companies over alleged fraudulent marketing and distribution of painkillers
-
NewsUS chemical assessment programme under fire
Environment agency’s integrated risk information system attacked at congressional hearing
-
NewsUS chemical lobby welcomes congressional probe of cancer research agency
House panel requests an NIH briefing about why it didn’t publish glyphosate study results
-
NewsMaterial lessons from Grenfell
Call for better testing and regulation on combustible building materials following last month’s deadly London fire
-
NewsCongress probes NIH backing of cancer agency
US congressional panel investigates why NIH funds IARC, questioning the agency’s process for classifying substances as carcinogenic
-
NewsNo health effects from chemicals from West Virginia spill
January 2014 leak from Freedom Industries’ site at levels too low to harm people’s health
-
NewsHollywood may have shaped Iraq war chemical weapons intel
Claim that nerve agents were stored in glass beads bears resemblance to action film
-
NewsEnquiry highlights ‘missing’ UK government research
Science group calls for a central database to improve public access to government-commissioned reports
-
NewsLitvinenko inquiry unveils scientific sleuths at heart of investigation
Anonymous forensic investigators and chemists tracked trail left by dissident’s killers